HP Ingredients’ LJ 100 recently received a safety confirmation from Intertek and a product license granting four new health claims from Health Canada.
HP Ingredients (Bradenton, FL) has announced two new completed regulatory and safety reviews for its LJ 100 tongkat ali (Eurycoma longifolia) ingredient: a safety confirmation from Intertek Scientific & Regulatory Consultancy and a product license from Health Canada granting four new health claims.
For the Intertek safety review, Barry Lynch, director of the food and nutrition group at Intertek, reviewed 56 human clinical and animal studies of LJ 100’s safety, mechanism of action, and efficacy for a range of reproductive support issues.
“The available information supports the safety of LJ 100 at the intake level of 200 mg per day,” concluded Lynch. He also noted that available data showed a lack of serious adverse effects at doses of 200–600 mg/day, further supporting the safety of a 200 mg/day dose.
“This review by Intertek further supports the safety of LJ 100 brand of standardized aqueous Eurycoma longifolia extract specifically and does not encompass generic tongkat ali alternatives,” says Annie Eng, founder and president, HP Ingredients.
The second development comes from Health Canada, which recently issued product license NPN #80067049 for LJ 100 capsules and granted four new health claims that are now allowed for Candian LJ 100 products at 100 mg and 200 mg doses. The permissible claims are that Eurycoma longifolia “helps support healthy sexual interest,” “helps promote testosterone production,” “supports testosterone production,” and “is a source of/provides antioxidants.”
“Our LJ 100 is one of the very few testosterone ingredients currently available on the market that has gone through this type of rigorous independent and third-party safety review,” says Hame Persaud, executive vice president, HP Ingredients. “At a time when free testosterone enhancing products are under intense scrutiny, this should lay to rest any concerns regarding the safety of LJ 100 for oral dosage use in dietary supplements at its clinically evaluated levels.”
Nutritional Outlook Magazine